stockrowPulse Biosciences, Inc
PLSE Healthcare Medical Instruments & Supplies
Pulse Biosciences, Inc’s revenue for fiscal 2025 (year ended December 2025) was $350,000.00, down 50.0% from fiscal 2022.
- Revenue
- +359.3%
- EPS
- −10.3%
- Free cash flow
- −1,180.5%
Quarter to September 2026, against a year earlier
Follow PLSE
Alert me
Pulse Biosciences, Inc (PLSE) Debt to equity
Pulse Biosciences, Inc's debt to equity at the end of the quarter to 30 September 2026 was 0.0×, down 0.0× from fiscal 2025 (0.0×). Over the past ten years it has ranged from −29.3× (fiscal 2022) to 0.5× (fiscal 2020); the current reading is higher than 73% of that period. That is below the Medical Instruments & Supplies industry median of 0.1× and in line with the Healthcare sector median of 0.0×.
Debt to equity, annual
Embed this chart
Annual newest first
| Period | Debt to equity | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | −29.3× | — |
| FY2021 | 0.3× | (36.45%) |
| FY2020 | 0.5× | 126.90% |
| FY2019 | 0.2× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | Debt to equity | Change |
|---|---|---|
| Sep 2026 | 0.0× | — |
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| 43 more quarters | Free account |
Against its own ten years
Debt to equity against peers
| Company | Debt to equity |
|---|---|
| WRBY Warby Parker Inc. compare | 0.0× |
| PLSE Pulse Biosciences, Inc | 0.0× |
| MMED MiniMed Group, Inc. compare | 0.0× |
| ATRC AtriCure, Inc. compare | 0.1× |
| STVN Stevanato Group S.p.A. compare | 0.3× |
| MMSI Merit Medical Systems, Inc. compare | 0.4× |
| NVST Envista Holdings Corporation compare | 0.5× |
| ICUI ICU Medical, Inc. compare | 0.5× |
| TFX Teleflex Incorporated compare | 1.0× |
| Medical Instruments & Supplies industry median | 0.1× |
| Healthcare sector median | 0.0× |
| Market median | 0.1× |
What Debt to equity is
Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.
(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)
More on PLSE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Altman Z-score
- The full statement